Zailab
The Director, Pharmacovigilance, Global Programs at Zai Lab provides scientific and strategic leadership for safety evaluation and risk management of oncology and neuroscience & immunology products across their lifecycle. The role oversees core pharmacovigilance activities, regulatory safety documentation, and inspection readiness while influencing cross‑functional stakeholders and senior leadership.
Headquarters
Pinelands, Western Cape, South Africa
Company Size
51-200 employees
Founded
2014
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zailab.
10% above the average for this role
Global Pharmacovigilance Medical Director
Beeline Medicines
Global Pharmacovigilance Manager
Amgen
Global Pharmacovigilance Senior Medical Director
Beeline Medicines
SERM Senior Scientific Director, Oncology
GSK plc
Director of Pharmacovigilance
Treeline Biosciences
Senior Director, Patient Safety & Pharmacovigilance
Latigobio